News | July 24, 2024
Syngene reports drop in Q1 FY25 revenue to Rs. 790 Cr
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Renews GMP certifications for India and Malaysia sites
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Automated parallel capillary electrophoresis system simplifies protein analysis
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
One thousand times more soluble than L-cystine at neutral pH
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
Subscribe To Our Newsletter & Stay Updated
